『UK MHRA ResMed Astral Alert: Ventilator Safety Actions for NatPSA/2026/004/MHRA』のカバーアート

UK MHRA ResMed Astral Alert: Ventilator Safety Actions for NatPSA/2026/004/MHRA

UK MHRA ResMed Astral Alert: Ventilator Safety Actions for NatPSA/2026/004/MHRA

無料で聴く

ポッドキャストの詳細を見る
The UK's MHRA issued National Patient Safety Alert NatPSA/2026/004/MHRA on August 17, 2026, for ResMed Astral 100 and 150 ventilators manufactured before October 2024. A faulty internal supercapacitor can leak, causing the device to shut down unexpectedly and risking serious injury or death. This episode details the specific device fault, the risks to patients, and the mandatory actions required by the MHRA for healthcare providers and manufacturers. We focus on the critical importance of post-market surveillance and immediate risk mitigation for life-sustaining devices. Key Questions: - What is the specific defect in ResMed Astral ventilators identified by the MHRA? - Which device models and manufacturing dates are covered by NatPSA/2026/004/MHRA? - What are the immediate risks to patients in hospital and home care settings? - What actions must healthcare providers take to ensure patient safety? - How does this alert impact post-market surveillance obligations for manufacturers of life-sustaining devices? - What is the role of backup ventilation for affected patients? - How can teams document their response to this MHRA safety alert for compliance? - What lessons can be learned about component traceability and supplier quality management? Sources: - https://www.gov.uk/alerts-and-recalls/national-patient-safety-alert-resmed-astral-100-and-150-ventilators-potential-for-patient-harm-due-to-unexpected-interruption-of-ventilation-therapy-natpsa-2026-004-mhra - https://dispex.net/news-alerts/national-patient-safety-alert-resmed-astral-100-and-150-ventilators/ - https://www.gov.uk/government/publications/mhra-safety-roundup-august-2026/mhra-safety-roundup-august-2026 How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech companies, ensuring products meet safety and performance standards from development to post-market surveillance. Our experts help you establish robust post-market surveillance systems, manage incident reporting, and execute field safety corrective actions efficiently. With local representation in over 30 markets, including the UK, we act as your in-country contact with authorities like the MHRA, ensuring timely communication and compliance. Leverage our AI-powered tools and global database at https://pureglobal.ai to streamline your regulatory processes and maintain market access. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn more.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません